Identification and verification of differentially expressed microRNAs and their target genes for the diagnosis of esophageal cancer

Cai,Xiaoyue; Yang,Xiwen; Jin,Changjuan; Li,Lei; Cui,Qing; Guo,Yijun; Dong,Yun; Yang,Xiaohua; Guo,Lili; Zhang,Ming

doi:10.3892/ol.2018.9066

Identification and verification of differentially expressed microRNAs and their target genes for the diagnosis of esophageal cancer

Authors:
- Xiaoyue Cai
- Xiwen Yang
- Changjuan Jin
- Lei Li
- Qing Cui
- Yijun Guo
- Yun Dong
- Xiaohua Yang
- Lili Guo
- Ming Zhang
View Affiliations

Affiliations: Department of Integrated Traditional Chinese Medicine and Western Medicine, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai 200030, P.R. China, Research Center, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai 200030, P.R. China
Published online on: July 4, 2018 https://doi.org/10.3892/ol.2018.9066
Pages: 3642-3650
Copyright: © Cai et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Bioinformatic tools were used to analyze GSE6188, GSE13937 and GSE43732 microarrays, and the top 10 upregulated and downregulated genes of each microarray were identified. It was determined that human microRNA (hsa‑miR)‑1 and hsa‑miR‑203 were two downregulated genes in common. Subsequently, it was identified that there were 145 and 335 genes in common targeted by hsa‑miR‑1 and hsa‑miR‑203, respectively. In order to narrow the number of target genes down further, the target genes were compared with GSE26886 microarray data. There were five upregulated genes in common with hsa‑miR‑1, i.e., MMD, BICD1, PTPRG, SDC2 and SEMA6D, and there were eight upregulated genes in common with hsa‑miR‑203, i.e., PXDN, NRCAM, FMNL2, EIF5A2, GLI3, FSL1, GREM1 and AHR. These genes may become promising biomarkers for the diagnosis of esophageal cancer.

View Figures

View References

1	International Agency for Research on Cancer (IARC): World Cancer Report 2014. Stewart BW and Wild CP: IARC; Lyon: 2014, http://publications.iarc.fr/Non-Series-Publications/World-Cancer-Reports/World-Cancer-Report-2014 View Article : Google Scholar
2	Ferri F: Ferri's Clinical Advisor 2014: 5 Books in 1. 1st edition. Mosby Elsevier; Philadelphia, PA: 2014
3	Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et al: Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the global burden of disease study 2010. Lancet. 380:2095–2128. 2012. View Article : Google Scholar : PubMed/NCBI
4	Enzinger PC and Mayer RJ: Esophageal cancer. N Engl J Med. 349:2241–2252. 2003. View Article : Google Scholar : PubMed/NCBI
5	Ambros V: The functions of animal microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
6	Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 116:281–297. 2004. View Article : Google Scholar : PubMed/NCBI
7	Võsa U, Vooder T, Kolde R, Fischer K, Välk K, Tõnisson N, Roosipuu R, Vilo J, Metspalu A and Annilo T: Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer. Genes Chromosomes Cancer. 50:812–822. 2011. View Article : Google Scholar : PubMed/NCBI
8	Akçakaya P, Ekelund S, Kolosenko I, Caramuta S, Ozata DM, Xie H, Lindforss U, Olivecrona H and Lui WO: miR-185 and miR-133b deregulation is associated with overall survival and metastasis in colorectal cancer. Int J Oncol. 39:311–318. 2011.PubMed/NCBI
9	Jones K, Nourse JP, Keane C, Bhatnagar A and Gandhi MK: Plasma microrna are disease response biomarkers in classical hodgkin lymphoma. Clin Cancer Res. 20:253–264. 2014. View Article : Google Scholar : PubMed/NCBI
10	Wu H and Mo YY: Targeting miR-205 in breast cancer. Expert Opin Ther Targets. 13:1439–1448. 2009. View Article : Google Scholar : PubMed/NCBI
11	Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y and Goodall GJ: The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol. 10:593–601. 2008. View Article : Google Scholar : PubMed/NCBI
12	Hsu SD, Chu CH, Tsou AP, Chen SJ, Chen HC, Hsu PW, Wong YH, Chen YH, Chen GH and Huang HD: miRNAMap 2.0: Genomic maps of microRNAs in metazoan genomes. Nucleic Acids Res. 36:D165–D169. 2008. View Article : Google Scholar : PubMed/NCBI
13	Friedman RC, Farh KK, Burge CB and Bartel DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19:92–105. 2009. View Article : Google Scholar : PubMed/NCBI
14	Kozomara A and Griffiths-Jones S: miRBase: Integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 39:D152–D157. 2011. View Article : Google Scholar : PubMed/NCBI
15	Griffiths-Jones S, Saini HK, van Dongen S and Enright AJ: miRBase: Tools for microRNA genomics. Nucleic Acids Res. 36:D154–D158. 2008. View Article : Google Scholar : PubMed/NCBI
16	Kertesz M, Iovino N, Unnerstall U, Gaul U and Segal E: The role of site accessibility in microRNA target recognition. Nat Genet. 39:1278–1284. 2007. View Article : Google Scholar : PubMed/NCBI
17	Zhang Y: Epidemiology of esophageal cancer. World J Gastroenterol. 19:5598–5606. 2013. View Article : Google Scholar : PubMed/NCBI
18	Guo H, Ingolia NT, Weissman JS and Bartel DP: Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature. 466:835–840. 2010. View Article : Google Scholar : PubMed/NCBI
19	Paranjape T, Slack FJ and Weidhaas JB: MicroRNAs: Tools for cancer diagnostics. Gut. 58:1546–1554. 2009. View Article : Google Scholar : PubMed/NCBI
20	Gulyaeva LF and Kushlinskiy NE: Regulatory mechanisms of microRNA expression. J Transl Med. 14:1432016. View Article : Google Scholar : PubMed/NCBI
21	Bian Z, Li LM, Tang R, Hou DX, Chen X, Zhang CY and Zen K: Identification of mouse liver mitochondria-associated miRNAs and their potential biological functions. Cell Res. 20:1076–1078. 2010. View Article : Google Scholar : PubMed/NCBI
22	Li P, Jiao J, Gao G and Prabhakar BS: Control of mitochondrial activity by miRNAs. J Cell Biochem. 113:1104–1110. 2012. View Article : Google Scholar : PubMed/NCBI
23	Reshmi G and Pillai MR: Beyond HPV: Oncomirs as new players in cervical cancer. FEBS Lett. 582:4113–4116. 2008. View Article : Google Scholar : PubMed/NCBI
24	Corté H, Manceau G, Blons H and Laurent-Puig P: MicroRNA and colorectal cancer. Dig Liver Dis. 44:195–200. 2012. View Article : Google Scholar : PubMed/NCBI
25	Anwar SL, Albat C, Krech T, Hasemeier B, Schipper E, Schweitzer N, Vogel A, Kreipe H and Lehmann U: Concordant hypermethylation of intergenic microRNA genes in human hepatocellular carcinoma as new diagnostic and prognostic marker. Int J Cancer. 133:660–670. 2013. View Article : Google Scholar : PubMed/NCBI
26	Nasser MW, Datta J, Nuovo G, Kutay H, Motiwala T, Majumder S, Wang B, Suster S, Jacob ST and Ghoshal K: Down-regulation of micro-rna-1 (mir-1) in lung cancer: Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by mir-1. J Biol Chem. 283:33394–33405. 2008. View Article : Google Scholar : PubMed/NCBI
27	Sokol NS and Ambros V: Mesodermally expressed Drosophila microRNA-1 is regulated by Twist and is required in muscles during larval growth. Genes Dev. 19:2343–2354. 2005. View Article : Google Scholar : PubMed/NCBI
28	Zhao Y, Samal E and Srivastava D: Serum response factor regulates a muscle-specific microRNA that targets hand2 during cardiogenesis. Nature. 436:214–220. 2005. View Article : Google Scholar : PubMed/NCBI
29	Mishima T, Mizuguchi Y, Kawahigashi Y and Takizawa T and Takizawa T: RT-PCR-based analysis of microRNA (miR-1 and −124) expression in mouse CNS. Brain Res. 1131:37–43. 2007. View Article : Google Scholar : PubMed/NCBI
30	Nohata N, Sone Y, Hanazawa T, Fuse M, Kikkawa N, Yoshino H, Chiyomaru T, Kawakami K, Enokida H, Nakagawa M, et al: miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma. Oncotarget. 2:29–42. 2011. View Article : Google Scholar : PubMed/NCBI
31	Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I and Inazawa J: miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis. 31:766–776. 2010. View Article : Google Scholar : PubMed/NCBI
32	Bueno MJ, de Castro Pérez I, de Cedrón Gómez M, Santos J, Calin GA, Cigudosa JC, Croce CM, Fernández-Piqueras J and Malumbres M: Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell. 13:496–506. 2008. View Article : Google Scholar : PubMed/NCBI
33	Lena AM, Shalom-Feuerstein R, di Val Cervo Rivetti P, Aberdam D, Knight RA, Melino G and Candi E: miR-203 represses' stemness' by repressing Np63. Cell death differ. 15:11872008. View Article : Google Scholar : PubMed/NCBI
34	Zang W, Wang Y, Du Y, Xuan X, Wang T, Li M, Ma Y, Li P, Chen X, Dong Z and Zhao G: Differential expression profiling of microRNAs and their potential involvement in esophageal squamous cell carcinoma. Tumor Biol. 35:3295–32304. 2014. View Article : Google Scholar